Standard

The Effect of Atypical Antipsychotic Drugs on the Neurotrophic Factors Gene Expression in the MPTP Model of Parkinson's Disease. / Tsybko, A. S.; Il'chibaeva, T. V.; Khotskin, N. V. и др.

в: Neurochemical Journal, Том 13, № 2, 04.2019, стр. 169-175.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Tsybko, AS, Il'chibaeva, TV, Khotskin, NV, Kovetskaya, AI, Naumenko, VS & Popova, NK 2019, 'The Effect of Atypical Antipsychotic Drugs on the Neurotrophic Factors Gene Expression in the MPTP Model of Parkinson's Disease', Neurochemical Journal, Том. 13, № 2, стр. 169-175. https://doi.org/10.1134/S1819712419020120

APA

Tsybko, A. S., Il'chibaeva, T. V., Khotskin, N. V., Kovetskaya, A. I., Naumenko, V. S., & Popova, N. K. (2019). The Effect of Atypical Antipsychotic Drugs on the Neurotrophic Factors Gene Expression in the MPTP Model of Parkinson's Disease. Neurochemical Journal, 13(2), 169-175. https://doi.org/10.1134/S1819712419020120

Vancouver

Tsybko AS, Il'chibaeva TV, Khotskin NV, Kovetskaya AI, Naumenko VS, Popova NK. The Effect of Atypical Antipsychotic Drugs on the Neurotrophic Factors Gene Expression in the MPTP Model of Parkinson's Disease. Neurochemical Journal. 2019 апр.;13(2):169-175. doi: 10.1134/S1819712419020120

Author

Tsybko, A. S. ; Il'chibaeva, T. V. ; Khotskin, N. V. и др. / The Effect of Atypical Antipsychotic Drugs on the Neurotrophic Factors Gene Expression in the MPTP Model of Parkinson's Disease. в: Neurochemical Journal. 2019 ; Том 13, № 2. стр. 169-175.

BibTeX

@article{607e9152d2c34efe8848df4884442e79,
title = "The Effect of Atypical Antipsychotic Drugs on the Neurotrophic Factors Gene Expression in the MPTP Model of Parkinson's Disease",
abstract = "Atypical antipsychotics (AAP) are used in the therapy of Parkinson's disease (PD) for elimination of psychotic symptoms. As the brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF) and cerebral dopamine neurotrophic factor (CDNF) play a crucial role in the PD treatment, the aim of our study was the investigation of the effects of chronic treatment with commonly used AAP, clozapine and quetiapine, on the motor behavior and the BDNF, GDNF and CDNF genes expression in the mouse brain in the PD model produced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Clozapine and quetiapine (1 mg/kg, i.p.) were administered 48 hours after the last MPTP injection, and treatment continued for the following 16 days. Then animals were euthanized, substantia nigra (SN), striatum (St) and hippocampus (Hc) were extracted for RT-PCR and tyrosine hydroxylase (TH) western blot assessment. MPTP treatment led to 50% depletion in the TH protein level in the St. MPTP caused significant decrease in both BDNF and GDNF mRNA level in the Hc and St, respectively. At the same time, increase in the GDNF expression in the MPTP + clozapine group in the SN was found. MPTP caused dramatic decrease in the CDNF mRNA level in the SN with simultaneous increase in the St. Both clozapine and quetiapine decreased it to a normal level in the St. The effect of AAP clozapine and quetiapine on the GDNF and CDNF genes expression in the pharmacological model of PD has been shown for the first time.",
keywords = "clozapine, quetiapine, BDNF, GDNF, CDNF, MPTP, DOPAMINE RELEASE, SUBSTANTIA-NIGRA, BDNF EXPRESSION, MOUSE MODEL, QUETIAPINE, HIPPOCAMPUS, SEROTONIN, PSYCHOSIS, BEHAVIOR",
author = "Tsybko, {A. S.} and Il'chibaeva, {T. V.} and Khotskin, {N. V.} and Kovetskaya, {A. I.} and Naumenko, {V. S.} and Popova, {N. K.}",
year = "2019",
month = apr,
doi = "10.1134/S1819712419020120",
language = "English",
volume = "13",
pages = "169--175",
journal = "Neurochemical Journal",
issn = "1819-7124",
publisher = "MAIK NAUKA/INTERPERIODICA/SPRINGER",
number = "2",

}

RIS

TY - JOUR

T1 - The Effect of Atypical Antipsychotic Drugs on the Neurotrophic Factors Gene Expression in the MPTP Model of Parkinson's Disease

AU - Tsybko, A. S.

AU - Il'chibaeva, T. V.

AU - Khotskin, N. V.

AU - Kovetskaya, A. I.

AU - Naumenko, V. S.

AU - Popova, N. K.

PY - 2019/4

Y1 - 2019/4

N2 - Atypical antipsychotics (AAP) are used in the therapy of Parkinson's disease (PD) for elimination of psychotic symptoms. As the brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF) and cerebral dopamine neurotrophic factor (CDNF) play a crucial role in the PD treatment, the aim of our study was the investigation of the effects of chronic treatment with commonly used AAP, clozapine and quetiapine, on the motor behavior and the BDNF, GDNF and CDNF genes expression in the mouse brain in the PD model produced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Clozapine and quetiapine (1 mg/kg, i.p.) were administered 48 hours after the last MPTP injection, and treatment continued for the following 16 days. Then animals were euthanized, substantia nigra (SN), striatum (St) and hippocampus (Hc) were extracted for RT-PCR and tyrosine hydroxylase (TH) western blot assessment. MPTP treatment led to 50% depletion in the TH protein level in the St. MPTP caused significant decrease in both BDNF and GDNF mRNA level in the Hc and St, respectively. At the same time, increase in the GDNF expression in the MPTP + clozapine group in the SN was found. MPTP caused dramatic decrease in the CDNF mRNA level in the SN with simultaneous increase in the St. Both clozapine and quetiapine decreased it to a normal level in the St. The effect of AAP clozapine and quetiapine on the GDNF and CDNF genes expression in the pharmacological model of PD has been shown for the first time.

AB - Atypical antipsychotics (AAP) are used in the therapy of Parkinson's disease (PD) for elimination of psychotic symptoms. As the brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF) and cerebral dopamine neurotrophic factor (CDNF) play a crucial role in the PD treatment, the aim of our study was the investigation of the effects of chronic treatment with commonly used AAP, clozapine and quetiapine, on the motor behavior and the BDNF, GDNF and CDNF genes expression in the mouse brain in the PD model produced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Clozapine and quetiapine (1 mg/kg, i.p.) were administered 48 hours after the last MPTP injection, and treatment continued for the following 16 days. Then animals were euthanized, substantia nigra (SN), striatum (St) and hippocampus (Hc) were extracted for RT-PCR and tyrosine hydroxylase (TH) western blot assessment. MPTP treatment led to 50% depletion in the TH protein level in the St. MPTP caused significant decrease in both BDNF and GDNF mRNA level in the Hc and St, respectively. At the same time, increase in the GDNF expression in the MPTP + clozapine group in the SN was found. MPTP caused dramatic decrease in the CDNF mRNA level in the SN with simultaneous increase in the St. Both clozapine and quetiapine decreased it to a normal level in the St. The effect of AAP clozapine and quetiapine on the GDNF and CDNF genes expression in the pharmacological model of PD has been shown for the first time.

KW - clozapine

KW - quetiapine

KW - BDNF

KW - GDNF

KW - CDNF

KW - MPTP

KW - DOPAMINE RELEASE

KW - SUBSTANTIA-NIGRA

KW - BDNF EXPRESSION

KW - MOUSE MODEL

KW - QUETIAPINE

KW - HIPPOCAMPUS

KW - SEROTONIN

KW - PSYCHOSIS

KW - BEHAVIOR

U2 - 10.1134/S1819712419020120

DO - 10.1134/S1819712419020120

M3 - Article

VL - 13

SP - 169

EP - 175

JO - Neurochemical Journal

JF - Neurochemical Journal

SN - 1819-7124

IS - 2

ER -

ID: 23291862